Anti-PO antibodies, while described as specific in some studies, are neither sensitive nor included in the current European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) or Systemic Lupus International Collaborating Clinics (SLICC) criteria for SLE classification [1,2]. This evidence concerns the gene PRB4 and systemic lupus erythematosus.